Xcout IntelJanux Therapeutics, Inc.
Janux Therapeutics is a biotechnology research company headquartered in San Diego, California, specializing in the development of novel T cell immunotherapies for oncology and related treatments.
Subscribe to see Janux Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Janux Therapeutics, Inc. at a glance
Janux Therapeutics, Inc. is a biotechnology company headquartered in San Diego, United States. It is publicly listed (JANX) with a market capitalisation of $1B. Xcout tracks 30 named people at Janux Therapeutics, Inc., including Charles Winter (Chief Technical Officer). Xcout recorded 22 job postings from Janux Therapeutics, Inc. in the last 90 days.
Janux Therapeutics, Inc. leadership
- Charles WinterChief Technical Officer
- Thomas DiraimondoChief Scientific Officer
- Janeen DoyleChief Corporate & Business Development Officer
- Tommy DiRaimondo, Ph.D.Chief Scientific Officer
- David Alan CampbellPresident, Co-Founder, CEO & Director
- David Campbell, Ph.D.Founder, President & Chief Executive Officer
24 more named people on record for Janux Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Janux Therapeutics, Inc.
Xcout recorded 22 job postings from Janux Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Janux Therapeutics, Inc.'s hiring signals →
Tech stack
Janux Therapeutics, Inc. competitors
A few of Janux Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Lynx Biosciences is an interdisciplinary biotechnology company founded in 2013 and headquartered in San Diego, California, while incubating at J&J JLABS. The company develops a proprietary multi-omic functional platform to advance immunotherapies and cancer treatments.
Quentis Therapeutics, Inc. is a biotechnology research company based in New York City that specializes in next-generation immuno-oncology research and drug discovery for cancer treatment.
Amphivena Therapeutics, Inc. is a clinical-stage biotechnology company located in California, United States, focused on immuno-oncology and proprietary T cell engager platforms.
Bakx Therapeutics, Inc. is a private biotechnology company founded in 2020 and based in New York, United States. The company specializes in pre-clinical oncology drug pipelines and novel therapeutics discovery.
Valora Therapeutics, Inc. is a pre-clinical stage biopharmaceutical and biotechnology company based in San Diego, California, pioneering a novel biologic platform to engineer targeted therapies and engage immunity.
TwoStep Therapeutics is a biotechnology research company launched in 2024 and headquartered in San Carlos, California. The company is developing a pipeline built around a versatile peptide that selectively binds multiple tumor-associated targets to bring new targeted therapies to cancer patients.
Get Janux Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Janux Therapeutics, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Janux Therapeutics, Inc. in Xcout Intel
- 30 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 2 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access